Ethadione
NERVOUS SYSTEM
Also known as: aethadion, didione, dimedion, dimedione, ethadionum, petidion
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Ethadione is a drug catalogued in DrugCentral. Recorded indications include Absence seizure and Epilepsy.
- Indications: Absence seizure and Epilepsy.
- ATC code: N03AC03 (Oxazolidine derivatives).
- Molecular formula: C7H11NO3; molecular weight 157.17 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Absence seizure
- Epilepsy
Contraindications (15)
- Acute nephropathy
- Disease of liver
- Disorder of optic nerve
- Eaton-Lambert syndrome
- Hepatic failure
- Kidney disease
- Leukopenia
- Lupus erythematosus and erythema multiforme-like syndrome
- Lymphadenopathy
- Neutropenic disorder
- Porphyria
- Pregnancy, function
- Proteinuria
- Retinal disorder
- Thrombocytopenic disorder
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N03AC03 | NERVOUS SYSTEM › ANTIEPILEPTICS › ANTIEPILEPTICS › Oxazolidine derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Ethadione is on its molecule page.
| Molecular formula | C7H11NO3 |
|---|---|
| Molecular weight | 157.17 g/mol |
| CAS number | 520-77-4 |
| InChIKey | SIGSNYAYBSJATD-UHFFFAOYSA-N |
| PubChem CID | 10630 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Ethadione used for?
DrugCentral lists the following indications for Ethadione: Absence seizure and Epilepsy.
What is the chemical formula of Ethadione?
Ethadione has the molecular formula C7H11NO3 and a molecular weight of 157.17 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1072 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL93047 — compound record and bioactivity
- PubChem CID 10630 — chemical identifiers
- DrugBank DB13799 — drug record
- FDA UNII I0F8O700BB — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.